Palvella Therapeutics, Inc. filed its quarterly report on Form 10-Q with the SEC on November 5, 2026, covering the fiscal quarter ended September 30, 2026.
A Form 4 filed on November 5, 2026 reports that Bryan T. Vaughn, EVP and President, Diagnostics at Labcorp Holdings Inc., sold 306 shares of common stock on November 3, 2026 under a Rule 10b5-1 trading plan.
SCYNEXIS, Inc. filed its quarterly report on Form 10-Q with the SEC on November 5, 2026, covering the fiscal quarter ended September 30, 2026, and reporting a net loss of $22.360 million for the nine months ended on that date.
Sabre Corporation filed its quarterly report on Form 10-Q with the SEC on November 5, 2026, covering the three and nine months ended September 30, 2026, disclosing continued revenue growth alongside a net loss from continuing operations and rising long-term debt.
BlackRock TCP Capital Corp. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 5, 2026, reporting a net decrease in net assets from operations of $81,305,680 for the nine months ended September 30, 2026.
Portillo's Inc. filed its quarterly report on Form 10-Q for the fiscal quarter ended September 27, 2026, with the SEC on November 5, 2026, reporting 72,766,838 shares of Class A common stock outstanding as of October 29, 2026.
Shattuck Labs, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 5, 2026, disclosing its financial position and operations as a clinical-stage biopharmaceutical company.
Portillo's Inc. filed a Form 8-K on November 5, 2026, disclosing third-quarter financial results and a Board-approved plan to close a mid-to-high single digit number of underperforming restaurants located outside of Chicagoland.
Veracyte, Inc. filed its quarterly report on Form 10-Q with the SEC on November 5, 2026, covering the fiscal quarter ended September 30, 2026, and reporting condensed consolidated financial results for the three and nine months ended on that date.
BlackRock TCP Capital Corp. filed a Form 8-K on November 5, 2026, announcing its financial results for the third quarter ended September 30, 2026, and declaring a fourth-quarter dividend of $0.17 per share.